Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
American Journal of Clinical Oncology
|
April 3, 2020
Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
Kathryn J Hammer, Vanessa C Copeland, Elizabeth T Loggers, et al.
Rare Tumors
|
November 2, 2013
Multiple liver abscess formation and primary gastrointestinal stromal tumor
Amy E Chang, Gary N Mann, Benjamin Hoch, et al.
Human Pathology
|
June 9, 2014
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics
George Jour, John D Scarborough, Robin L Jones, et al.
Expert Review of Anticancer Therapy
|
March 27, 2014
The multidisciplinary management of giant cell tumor of bone
Vincent Y Ng, Darin J Davidson, Edward Y Kim, et al.
Current Oncology Reports
|
March 17, 2026
Revisiting the Immune Frontier in Soft Tissue Sarcomas
Nadeem Bilani, Nourhane Al Akoum, Rusul Al-Marayaty, et al.
Oncoimmunology
|
February 1, 2020
Durable tumor regression in highly refractory metastatic <i>KIT/PDGFRA</i> wild-type GIST following treatment with nivolumab
Brett A Schroeder, Karan Kohli, Ryan B O'Malley, et al.
AJR. American Journal of Roentgenology
|
November 2, 2017
Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas
David B Pierce, Guy E Johnson, Eric Monroe, et al.
The Oncologist
|
June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma
Vinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.
Pathology, Research and Practice
|
June 25, 2021
Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis
Borislav A Alexiev, Brian S Finkelman, Lukas Streich, et al.
Archives of Pathology & Laboratory Medicine
|
August 20, 2024
Use of Mitotic Activity and the Size of Any Dedifferentiated Component for Risk Assessment in MDM2-Amplified Liposarcoma
Hao Wu, Madina Sukhanova, Haiming Tang, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
American Journal of Clinical Oncology
|
April 3, 2020
Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
Kathryn J Hammer, Vanessa C Copeland, Elizabeth T Loggers, et al.
Rare Tumors
|
November 2, 2013
Multiple liver abscess formation and primary gastrointestinal stromal tumor
Amy E Chang, Gary N Mann, Benjamin Hoch, et al.
Human Pathology
|
June 9, 2014
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics
George Jour, John D Scarborough, Robin L Jones, et al.
Expert Review of Anticancer Therapy
|
March 27, 2014
The multidisciplinary management of giant cell tumor of bone
Vincent Y Ng, Darin J Davidson, Edward Y Kim, et al.
Current Oncology Reports
|
March 17, 2026
Revisiting the Immune Frontier in Soft Tissue Sarcomas
Nadeem Bilani, Nourhane Al Akoum, Rusul Al-Marayaty, et al.
Oncoimmunology
|
February 1, 2020
Durable tumor regression in highly refractory metastatic <i>KIT/PDGFRA</i> wild-type GIST following treatment with nivolumab
Brett A Schroeder, Karan Kohli, Ryan B O'Malley, et al.
AJR. American Journal of Roentgenology
|
November 2, 2017
Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas
David B Pierce, Guy E Johnson, Eric Monroe, et al.
The Oncologist
|
June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma
Vinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.
Pathology, Research and Practice
|
June 25, 2021
Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis
Borislav A Alexiev, Brian S Finkelman, Lukas Streich, et al.
Archives of Pathology & Laboratory Medicine
|
August 20, 2024
Use of Mitotic Activity and the Size of Any Dedifferentiated Component for Risk Assessment in MDM2-Amplified Liposarcoma
Hao Wu, Madina Sukhanova, Haiming Tang, et al.
Page
of 11